newsfilter
← Latest News
GlobeNewswire·

KetamineOne Subsidiary KGK Science Helps Client Receive New Dietary Ingredient Status from U.S. FDA

VANCOUVER, British Columbia, Dec. 02, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (FRA: MY0), a company focused on consolidating medical clinics and becoming a North American leader in